The acute impact of continuous positive airway pressure on nasal resistance: A randomized controlled comparison

Journal of Applied Physiology

Volumn 102, Issue 3, 2007, Pages 1214-1219

  Willing, Stephanie ^a   San Pedro, Maybelle ^a   Driver, Helen S ^a   Munt, Peter ^a   Fitzpatrick, Michael F ^a,b  

^a QUEEN S UNIVERSITY   (Canada)

^b NONE   (Canada)

Author keywords

Nose; Treatment; Upper airway

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; NOSE AIRFLOW; NOSE AIRWAY RESISTANCE; NOSE OBSTRUCTION; OXYGEN MASK; PEAK EXPIRATORY FLOW; POSITIVE END EXPIRATORY PRESSURE; PRESSURE GRADIENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP APNEA SYNDROME;

ADULT; AIRWAY RESISTANCE; CONTINUOUS POSITIVE AIRWAY PRESSURE; CROSS-OVER STUDIES; FEMALE; HUMANS; HUMIDITY; INFLAMMATION; MALE; NASAL MUCOSA; NASAL OBSTRUCTION; TEMPERATURE;

EID: 33847749524     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00639.2006     Document Type: Article

References (38)

1. Annesi-Maesano I, Didier A, Klossek M, Chanal I, Moreau D, Bousquet J. The score for allergic rhinitis (SFAR): a simple and valid assessment method in population studies. Allergy 57: 107-114, 2002.
2. Bachour A, Hurmerinta K, Maasilta P. Mouth closing device (chinstrap) reduces mouth leak during nasal CPAP. Sleep Med 5: 261-267, 2004.
3. Bachour A, Maasilta P. Mouth breathing compromises adherence to nasal continuous positive airway pressure therapy. Chest 126: 1248-1254, 2004.
4. Barbe F, Pons S, Togores B, Sauleda J, Soler R, Agusti AG. Continuous positive airway pressure is effective in treating upper airway oedema. Eur Respir J 9: 1092-1093, 1996.
5. Bossi R, Piatti G, Roma E, Ambrosetti U. Effects of long-term nasal continuous positive airway pressure therapy on morphology, function, and mucociliary clearance of nasal epithelium in patients with obstructive sleep apnea syndrome. Laryngoscope 114: 1431-1434, 2004.
6. Brander PE, Soirinsuo M, Lohela P. Nasopharyngeal symptoms in patients with obstructive sleep apnea syndrome. Effect of nasal CPAP treatment. Respiration 66: 128-135, 1999.
7. Chervin RD, Theut S, Bassetti C, Aldrich MS. Compliance with nasal CPAP can be improved by simple Interventions. Sleep 20: 284-289, 1997.
8. Constantinidis J, Knobber D, Steinhart H, Kuhn J, Iro H. Fine-structural investigations of the effect of nCPAP-mask application on the nasal mucosa. Acta Otolaryngol 120: 432-437, 2000.
9. Day JH, Briscoe M, Widlitz MD. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit. J Allergy Clin Immunol 101: 638-645, 1998.
10. Desfonds P, Planes C, Fuhrman C, Foucher A, Raffestin B. Nasal resistance in snorers with or without sleep apnea: effect of posture and nasal ventilation with continuous positive airway pressure. Sleep 21: 625-632, 1998.
11. Eccles R. Nasal airway resistance and nasal sensation of airflow. Rhinol Suppl 14: 86-90, 1992.
12. Engleman HM, Cheshire KE, Deary IJ, Douglas NJ. Daytime sleepiness, cognitive performance and mood after continuous positive airway pressure for the sleep apnoea/hypopnoea syndrome. Thorax 48: 911-914, 1993.
13. Engleman HM, Martin SE, Deary IJ, Douglas NJ. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet 343: 572-575, 1994.
14. Fitzpatrick MF, Driver HS, Chatha N, Voduc N, Girard AM. Partitioning of inhaled ventilation between the nasal and oral routes during sleep in normal subjects. J Appl Physiol 94: 883-890, 2003.
15. Flemons WW, Reimer MA. Measurement properties of the calgary sleep apnea quality of life index. Am J Respir Crit Care Med 165: 159-164, 2002.
16. Harsch IA, Schahin SP, Bruckner K, Radespiel-Troger M, Fuchs FS, Hahn EG, Konturek PC, Lohmann T, Ficker JH. The effect of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnoea syndrome and type 2 diabetes. Respiration 71: 252-259, 2004.
17. Hayes MJ, McGregor FB, Roberts DN, Schroter RC, Pride NB. Continuous nasal positive airway pressure with a mouth leak: effect on nasal mucosal blood flux and nasal geometry. Thorax 50: 1179-1182, 1995.
18. Hudgel DW, Robertson DW. Nasal resistance during wakefulness and sleep in normal man. Acta Otolaryngol (Stockh) 98: 130-135, 1984.
19. Issa FG, Sullivan CE. The immediate effects of nasal continuous positive airway pressure treatment on sleep pattern in patients with obstructive sleep apnea syndrome. Electroencephalogr Clin Neurophysiol 63: 10-17, 1986.
20. Laine MT, Warren DW. Perceptual and respiratory responses to added nasal airway resistance loads in older adults. Laryngoscope 105: 425-428, 1995.
21. Lofaso F, Coste A, d'Ortho MP, Zerah-Lancner F, Delclaux C, Goldenberg F, Harf A. Nasal obstruction as a risk factor for sleep apnoea syndrome. Eur Respir J 16: 639-643, 2000.
22. Mabry RL. Rhinitis medicamentosa: the forgotten factor in nasal obstruction. South Med J 75: 817-819, 1982.
23. Massie CA, Hart RW, Peralez K, Richards GN. Effects of humidification on nasal symptoms and compliance in sleep apnea patients using continuous positive airway pressure. Chest 116: 403-408, 1999.
24. McLean HA, Urton AM, Driver HS, Tan AK, Day AG, Munt PW, Fitzpatrick MF. Effect of treating severe nasal obstruction on the severity of obstructive sleep apnoea. Eur Respir J 25: 521-527, 2005.
25. Miljeteig H, Cole P, Haight JSJ. Nasal resistance in recumbency and sleep. Rhinology 33: 82-83, 1995.
26. Mooe T, Franklin KA, Holmstrom K, Rabben T, Wiklund U. Sleep-disordered breathing and coronary artery disease: long-term prognosis. Am J Respir Crit Care Med 164: 1910-1913, 2001.
27. Paludetti G, Ottaviani F, Rosignoli M, Almadori G, Pagliari J. Variazioni circadiane delle resistenze nasali nei soggetti normali. (Nasal resistance circadian rhythm in normal subjects.) Acta Otorhinol Ital 4: 445-455, 1984.
28. Pepin JL, Leger P, Veale D, Langevin B, Robert D, Levy P. Side effects of nasal continuous positive airway pressure in sleep apnea syndrome. Study of 193 patients in two French sleep centers. Chest 107: 375-381, 1995.
29. Randerath WJ, Meier J, Genger H, Domanski U, Ruhle KH. Efficiency of cold passover and heated humidification under continuous positive airway pressure. Eur Respir J 20: 183-186, 2002.
30. Rappai M, Collop N, Kemp S, deShazo R. The nose and sleep-disordered breathing: what we know and what we do not know. Chest 124: 2309-2323, 2003.
31. Richards GN, Cistulli PA, Ungar RG, Berthon-Jones M, Sullivan CE. Mouth leak with nasal continuous positive airway pressure increases nasal airway resistance. Am J Respir Crit Care Med 154: 182-186, 1996.
32. Rundcrantz H. Postural variations of nasal patency. Acta Otolaryngol 68: 435-443, 1969.
33. Ryan CF, Lowe AA, Li D, Fleetham JA. Magnetic resonance imaging of the upper airway in obstructive sleep apnea before and after chronic nasal continuous positive airway pressure therapy. Am Rev Respir Dis 144: 939-944, 1991.
34. Sanner BM, Tepel M, Markmann A, Zidek W. Effect of continuous positive airway pressure therapy on 24-hour blood pressure in patients with obstructive sleep apnea syndrome. Am J Hypertens 15: 251-257, 2002.
35. Schrodter S, Biermann E, Halata Z. Histologic evaluation of nasal epithelium of the middle turbinate in untreated OSAS patients and during nCPAP therapy. Rhinology 42: 153-157, 2004.
36. Schwab RJ, Pack AI, Gupta KB, Metzger LJ, Oh E, Getsy JE, Hoffman EA, Gefter WB. Upper airway and soft tissue structural changes induced by CPAP in normal subjects. Am J Respir Crit Care Med 154: 1106-1116, 1996.
37. Winck JC, Delgado JL, Almeida JM, Marques JA. Heated humidification during nasal continuous positive airway pressure for obstructive sleep apnea syndrome: objective evaluation of efficacy with nasal peak inspiratory flow measurements. Am J Rhinol 16: 175-177, 2002.
38. Young T, Finn L, Kim H. Nasal obstruction as a risk factor for sleep-disordered breathing. The University of Wisconsin Sleep and Respiratory Research Group. J Allergy Clin Immunol 99: S757-S762, 1997.